Despite the market downturn, BIO is expecting a substantial increase in anticipated investor participation in the Seventh Annual BIO Investor Forum, taking place Oct. 29-31 in San Francisco, Calif. at the Palace Hotel. More than 240 venture capital and public market investors are expected to attend – representing a 40 percent increase in participation compared to 2007. A list of the companies of registered investors can be found at

Agricultural biotechnology is a science that allows plant breeders to make precise genetic changes to place beneficial traits – such as pest resistance, disease resistance or herbicide tolerance – into plants.

Pfizer and Eli Lilly have been noteworthy with respect to their efforts to produce responsible innovations this week.  Pfizer is advancing responsible stem cell research by currently focusing on induced pluripotent stem cells (iPs) and Eli Lilly is setting a great example regarding industry disclosures and increased transparency.

Hematology, Fibromyalgia, Osteoporosis, Huntington's Disease, and Cystic Fibrosis are among the therapeutic workshop topics to be presented at the Seventh Annual BIO Investor Forum, taking place October 29-31, 2008 at the Palace Hotel in San Francisco, Calif.


John Sheehan, president of PAS, Inc., VP of strategy and sustainable development at LiveFuels Inc., and formerly with the U.S. DOE's National Renewable Energy Laboratory, calls for moving the dialogue forward to fully understand the global effects of biofuels.

Chris Somerville, director of the Energy Biosciences Institute at UC Berkeley, Lawrence Berkeley National Lab and University of Illinois Urbana-Champaign, imagines what the United States’ energy future could look like with advanced research in this presentation at BIO’s Pacific Rim Summit on Industrial Biotechnology and Bioenergy in Vancouver Sept. 10.

Drew Endy, assistant professor, Department of Bioengineering, Stanford University, discusses the opportunities and challenges of establishing a new university-level curriculum in the new field of synthetic biology, what students want to learn and the biotech tools available to them. The presentation was given at the Pacific Rim Summit on Industrial Biotechnology and Bioenergy in Vancouver on Sept. 11.

Hey check it out! BIO's very own Brent Erickson discusses the future of ethanol with Dr. Moira Gunn on Tech Nation. Listen to the interview.

Reserve your spot for this national forum for late-stage private and emerging companies. What to expect:

BIO and its members engaged in animal biotechnology support a strong federal regulatory system to oversee development and approval of all genetically engineered (GE) animals and the products derived from them.

We have used the biological processes of microorganisms for 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products.

BIO recently hosted a conference call for bloggers interested in the topic of biofuels.